Completed PHASE4 INTERVENTIONAL 2-arm NCT00159419

Bisphosphonate Therapy for Osteogenesis Imperfecta

Sponsor: Indiana University School of Medicine

Conditions Osteogenesis Imperfecta Osteoporosis Paget Disease of Bone

Updated 7 times since 2017 Last updated: May 17, 2017 Started: Aug 31, 1999 Primary completion: Aug 31, 2008 Completion: Aug 31, 2008

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00159419, this PHASE4 trial focuses on Osteogenesis Imperfecta and Osteoporosis and remains completed. Sponsored by Indiana University School of Medicine, it has been updated 7 times since 1999, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2023 — Jul 2024 [monthly]

Completed PHASE4
Dec 2022 — Jan 2023 [monthly]

Completed PHASE4
Jan 2021 — Dec 2022 [monthly]

Completed PHASE4

▶ Show 2 earlier versions

Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

Aug 1999

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Indiana University School of Medicine

Data source: Indiana University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.